Zai Lab (09688) Schedules 26–27 Mar Board Meeting to Approve 2025 Annual Results; HK Release to Align with U.S. GAAP Filing

Bulletin Express

Mar 16

Zai Lab Limited has announced that its board of directors will meet on 26 March 2026 (U.S. Eastern Time) / 27 March 2026 (Hong Kong Time) to consider and approve the group’s annual results for the year ended 31 December 2025, prepared in accordance with the Hong Kong Listing Rules.

The forthcoming Hong Kong announcement will present the same financial figures previously disclosed under U.S. GAAP and filed with the U.S. Securities and Exchange Commission on 26 February 2026. Additional disclosures required by the HK Listing Rules, including a reconciliation from U.S. GAAP to International Financial Reporting Standards, will be provided.

Chairperson and CEO Dr. Samantha Du signed the notice on 16 March 2026. The company’s board currently consists of two executive directors and seven independent directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1171844938"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1171844938\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1171844938?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 22:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171844938","market":"us","top_or_hot":-1,"title":"Zai Lab (09688) Schedules 26–27 Mar Board Meeting to Approve 2025 Annual Results; HK Release to Align with U.S. GAAP Filing","media":"Bulletin Express","content":"<p>Zai Lab Limited has announced that its board of directors will meet on 26 March 2026 (U.S. Eastern Time) / 27 March 2026 (Hong Kong Time) to consider and approve the group’s annual results for the year ended 31 December 2025, prepared in accordance with the Hong Kong Listing Rules.</p>\n<p>The forthcoming Hong Kong announcement will present the same financial figures previously disclosed under U.S. GAAP and filed with the U.S. Securities and Exchange Commission on 26 February 2026. Additional disclosures required by the HK Listing Rules, including a reconciliation from U.S. GAAP to International Financial Reporting Standards, will be provided.</p>\n<p>Chairperson and CEO Dr. Samantha Du signed the notice on 16 March 2026. The company’s board currently consists of two executive directors and seven independent directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zai Lab (09688) Schedules 26–27 Mar Board Meeting to Approve 2025 Annual Results; HK Release to Align with U.S. GAAP Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZai Lab (09688) Schedules 26–27 Mar Board Meeting to Approve 2025 Annual Results; HK Release to Align with U.S. GAAP Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 22:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zai Lab Limited has announced that its board of directors will meet on 26 March 2026 (U.S. Eastern Time) / 27 March 2026 (Hong Kong Time) to consider and approve the group’s annual results for the year ended 31 December 2025, prepared in accordance with the Hong Kong Listing Rules.</p>\n<p>The forthcoming Hong Kong announcement will present the same financial figures previously disclosed under U.S. GAAP and filed with the U.S. Securities and Exchange Commission on 26 February 2026. Additional disclosures required by the HK Listing Rules, including a reconciliation from U.S. GAAP to International Financial Reporting Standards, will be provided.</p>\n<p>Chairperson and CEO Dr. Samantha Du signed the notice on 16 March 2026. The company’s board currently consists of two executive directors and seven independent directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09688","symbol_name":"再鼎医药","start_time":0,"source_url":"","article_id":"1171844938","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171844938","pubTimestamp":1773670890,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zai Lab Limited has announced that its board of directors will meet on 26 March 2026 (U.S. Eastern Time) / 27 March 2026 (Hong Kong Time) to consider and approve the group’s annual results for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09688":"再鼎医药"},"translate_title":"再鼎医药(09688)定于3月26日至27日召开董事会批准2025年全年业绩；香港发布与美国公认会计准则备案保持一致","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1},"content_text":"Zai Lab Limited has announced that its board of directors will meet on 26 March 2026 (U.S. Eastern Time) / 27 March 2026 (Hong Kong Time) to consider and approve the group’s annual results for the year ended 31 December 2025, prepared in accordance with the Hong Kong Listing Rules.\nThe forthcoming Hong Kong announcement will present the same financial figures previously disclosed under U.S. GAAP and filed with the U.S. Securities and Exchange Commission on 26 February 2026. Additional disclosures required by the HK Listing Rules, including a reconciliation from U.S. GAAP to International Financial Reporting Standards, will be provided.\nChairperson and CEO Dr. Samantha Du signed the notice on 16 March 2026. The company’s board currently consists of two executive directors and seven independent directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}